These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 5614843

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP, Bobrenko GV, Vashchenko TN, Simonova GP.
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic antifibrinolytic action of the potato protease inhibitor and epsilon-aminocaproic acid.
    Worowski K.
    Acta Biol Acad Sci Hung; 1976 Jun; 27(2-3):125-8. PubMed ID: 140568
    [Abstract] [Full Text] [Related]

  • 5. [Regulation of fibrinolysis and anti-fibrinolytic activity of the serum in children].
    Alekseenko IF.
    Sov Zdravookhr Kirg; 1969 Jun; 6():18-22. PubMed ID: 5375017
    [No Abstract] [Full Text] [Related]

  • 6. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
    Lukasiewicz H, Niewiarowski S.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):584-92. PubMed ID: 4236825
    [No Abstract] [Full Text] [Related]

  • 7. [Inveestigation of the inhibition of fibrinolysis using epsilon-aminocapronic acid].
    Stenszky E, Aszódi L, Hatvani I.
    Acta Pharm Hung; 1968 Jun 31; 38(2):191-6. PubMed ID: 5723266
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Fibrinolytic inhibitors].
    Nagamatsu A.
    Saishin Igaku; 1966 Feb 31; 21(2):320-5. PubMed ID: 5966316
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Inhibitors of fibrinolysis. (Our experience with epsilon-aminocaproic acid and the Kunitz inhibitor)].
    Babío San Salvador JL, Iriarte Ezcurdia JA, Ezcurra Cebreiro JM.
    Rev Clin Esp; 1965 Nov 30; 99(4):249-52. PubMed ID: 5863279
    [No Abstract] [Full Text] [Related]

  • 15. [Localized fibrinolysis of the tonsil and antiplasmin compounds].
    Asaga M, Okamoto M, Asaga H, Kimura M.
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb 30; 74(2):462-3. PubMed ID: 5106660
    [No Abstract] [Full Text] [Related]

  • 16. The effects of some synthetic compounds on in vitro fibrinolytic activity measured by different methods and the relevance to activity in vivo.
    Baillie AJ, Sim AK.
    Thromb Diath Haemorrh; 1972 Dec 31; 28(3):351-8. PubMed ID: 4265316
    [No Abstract] [Full Text] [Related]

  • 17. [The development of fibrinolysis inhibitors].
    Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967 Dec 31; 87(1):5-14. PubMed ID: 4173881
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of gastric plasmin activity by epsilon-aminocaproic acid.
    Thomson JM, Turner L, Poller L.
    Ann R Coll Surg Engl; 1973 Dec 31; 53(6):340-7. PubMed ID: 4271260
    [No Abstract] [Full Text] [Related]

  • 19. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F.
    Internist (Berl); 1966 Aug 31; 7(8):400-5. PubMed ID: 4863412
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.